Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, (Q36408990)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, |
scientific article |
Statements
1 reference
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, (English)
1 reference
Dena R Howard
1 reference
Talha Munir
1 reference
Lucy McParland
1 reference
Andy C Rawstron
1 reference
Anna Chalmers
1 reference
Walter M Gregory
1 reference
John L O'Dwyer
1 reference
Alison Smith
1 reference
Roberta Longo
1 reference
Abraham Varghese
1 reference
Alexandra Smith
1 reference
1 May 2017
1 reference
1 reference
21
1 reference
28
1 reference
1-374
1 reference
Identifiers
1 reference
1 reference